West Pharmaceutical Services, Inc. WST
409.93 USD +10.12 (+2.53%)
Nov 9, 2026, 2:25 PM EST
398.14 Day range 410.79
230.95 52-week range 416.67
- YTD
- +48.99%
- 1 year
- +51.24%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.07B | 2.89B | 2.95B | 2.89B | 2.83B | |
| 1.10B | 998.50M | 1.13B | 1.14B | 1.18B | |
| 584.90M | 569.90M | 676.00M | 734.00M | 752.30M | |
| 493.70M | 492.70M | 593.40M | 585.90M | 661.80M | |
| 6.79 | 6.69 | 7.88 | 7.73 | 8.67 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 791.30M | 484.60M | 853.90M | 894.30M | 762.60M | |
| 4.27B | 3.64B | 3.83B | 3.62B | 3.31B | |
| 1.09B | 961.10M | 948.50M | 931.90M | 978.40M | |
| 321.10M | 302.30M | 309.00M | 317.90M | 325.30M | |
| 3.18B | 2.68B | 2.88B | 2.68B | 2.34B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 754.80M | 653.40M | 776.50M | 724.00M | 584.00M | |
| -285.90M | -378.70M | -368.70M | -288.20M | -253.10M | |
| -185.10M | -622.60M | -459.60M | -293.60M | -168.10M | |
| -285.90M | -377.00M | -362.00M | -284.60M | -253.40M | |
| 306.70M | -369.30M | -40.40M | 131.70M | 147.10M |